Immunological Evaluation of Recent MUC1 Glycopeptide Cancer Vaccines

Aberrantly glycosylated mucin 1 (MUC1) is a recognized tumor-specific antigen on epithelial cell tumors. A wide variety of MUC1 glycopeptide anti-cancer vaccines have been formulated by many research groups. Some researchers have used MUC1 alone as an immunogen whereas other groups used different an...

Descripción completa

Detalles Bibliográficos
Autores principales: Hossain, Md Kamal, Wall, Katherine A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041019/
https://www.ncbi.nlm.nih.gov/pubmed/27472370
http://dx.doi.org/10.3390/vaccines4030025

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041019/
https://www.ncbi.nlm.nih.gov/pubmed/27472370
http://dx.doi.org/10.3390/vaccines4030025

Ejemplares similares